HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC.

Highlights Harvard Apparatus Regenerative Technology Inc.

Equities

HRGN

US09074M2026

Market Closed - OTC Markets Other stock markets 01:15:13 28/06/2024 am IST			5-day change	1st Jan Change
2.921 ^USD	-0.31%		+11.49%	-41.46%

13/05	Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
15/04	Harvard Apparatus Regenerative Technology Inc. announced that it expects to receive $1.482101 million in funding	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11	CI
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Biostage, Inc. Activated Mayo Clinic as the First Site for Clinical Trial in Severe Esophageal Disease	18/23/18	CI
Biostage, Inc. Initiates Study Start-Up Activities for Clinical Trial in Severe Esophageal Disease	31/23/31	CI
Biostage Initiates Study Start-Up Activities for Clinical Trial in Severe Esophageal Disease	31/23/31	CI
Biostage, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	13/23/13	CI
Biostage, Inc. Appoints Ron Packard to Board of Directors	10/23/10	CI
Biostage, Inc. Announces New Publication Demonstrates Rapid Esophageal Regeneration Using the Biostage Esophageal Implant	23/22/23	CI
Biostage, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
Biostage, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	05/22/05	CI
Biostage, Inc. Announces Publication of Mechanical Strength Data for Regenerated Esophageal Tissue in Journal of Biomechanics	15/22/15	CI
Biostage, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	17/22/17	CI
Biostage, Inc. Announces $5.1 Million Financing to Advance Clinical Trial	13/22/13	CI
Biostage, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	01/22/01	CI
Biostage Says Court Orders Medical Liability Insurance Carrier to Pay Its Litigation Costs; Shares Rise	26/22/26	MT
Biostage Announces Publication of Paper Establishing the Basis for Using its Product to Treat Birth Defects in the Esophagus in Babies	11/22/11	CI
Biostage, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	16/21/16	CI
Biostage, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	14/21/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Harvard Apparatus Regenerative Technology Inc.

Equities

HRGN

US09074M2026

Highlights

Filters